Hikari Miura

Hirosaki University

Papers

1

Total Citations

5

H-Index

1

About

Dr. Hikari Miura is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for muscle-invasive bladder cancer (MIBC). Her major contribution lies in rigorously comparing robot-assisted radical cystectomy (RARC) against traditional open surgery, specifically investigating its impact on peritoneal carcinomatosis and long-term prognosis. In her landmark 2025 multicenter retrospective study, Dr. Miura analyzed data from 429 patients, providing critical real-world evidence on the oncologic safety and efficacy of robotic approaches. This work, already garnering 5 citations shortly after publication, addresses a pivotal clinical debate and helps guide surgical decision-making for high-risk patients. By demonstrating the comparative outcomes of these techniques, her research directly informs best practices in urologic oncology, aiming to reduce complications and improve survival. Dr. Miura’s dedication to evidence-based surgery and her focus on translating complex clinical data into actionable insights make her a rising authority in the field, with her findings poised to shape future treatment protocols for MIBC.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Effects of Robot‐Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle‐Invasive Bladder Cancer: A Multicenter Retrospective Study
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Hirosaki University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago